AT&T’s stock nudged down 0.9% on Monday, closing at $27.36 after dipping to $27.16 intraday—on curiously quiet trading volume ...

Progressive’s Q1 earnings call blended turbo-charged growth with a few economic potholes. Personal auto applications surged ...

BNP Paribas upped its investment in Prologis by 7.7% in Q4, acquiring over 11,000 new shares worth $16.7 million. Other major ...

EVP David Christopher Raymond sold 3,899 Boeing shares, totaling over $729K, trimming his holdings by 8.4%. The transaction ...

Brown Advisory trimmed nearly 20% of its TJX Companies holdings, offloading 833,178 shares in Q4, lowering its stake to 0.30% ...

Schonfeld Strategic Advisors gave its Deere & Company stake a steroid shot, boosting holdings by 814.3% last quarter. They ...

Analysts have trimmed Airbnb’s financial wings, with Citigroup lowering its price target from $170 to $155 while still ...

Vertex Pharmaceuticals hit a rough patch in Q1, reporting weaker-than-expected earnings and halting an early mRNA cystic ...

Cantor Fitzgerald gave Regeneron a financial pick-me-up by nudging its 2025 EPS forecast to $26.88 from $26.38. This slight ...

Bristol-Myers Squibb appointed Cari Gallman as EVP, General Counsel, and Chief Policy Officer, replacing retiring Sandra ...

Guggenheim’s Jason Cassorla gave Cigna’s outlook a caffeine jolt, raising the target price to $388 while maintaining a “Buy” ...

Alteri Wealth LLC made a new move, snapping up $339,000 worth of Marsh & McLennan Companies stock, joining a parade of hedge ...